1-2 of 2
Rabecka Martin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease

Frits van Rhee, Adam Rosenthal, Karan Kanhai, Rabecka Martin, Katherine Nishimura, Antje Hoering, David C. Fajgenbaum
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4773–4781.
https://doi.org/10.1182/bloodadvances.2022007112
Published: 2022
Includes: Supplemental data
Journal Articles

Epidemiology and treatment patterns of idiopathic multicentric Castleman disease in the era of IL-6–directed therapy

Clinical Trials & Observations
Sudipto Mukherjee, Rabecka Martin, Brenda Sande, Jeremy S. Paige, David C. Fajgenbaum
Journal: Blood Advances
Blood Adv (2022) 6 (2): 359–367.
https://doi.org/10.1182/bloodadvances.2021004441
Published: 2022
Includes: Supplemental data